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The growth of a transplanted kidney in an anephric human
being, dog, or rat [1—5] proves that the principal stimulus (or
stimuli) to compensatory renal hypertrophy is carried in the
blood. The truth of this statement is based on the simplest
assay of compensatory growth—a parallel increase in renal
mass and protein content—and the fact that a heterotopic
transplanted kidney is divorced from all influences except those
carried in the blood. Although, to be sure, some parasympathet-
ic nerve fibers survive in the donor renal artery and vein,
sympathetic connections across the vascular anastomoses are
not detectable until a month after transplantation in humans and
about 3 months in dogs [6, 7].
Corroborative evidence from rats in crosscirculation shows
not only that the stimulus is humoral, but that it is short-lived
and needs to be present nearly all the time during the early
phases of compensatory growth [8, 91. In this model about 10%
of the blood volume of an anephric rat is exchanged every
minute with the blood of a rat retaining both kidneys; the two
rats in essence become one.
The kinetics of growth and the RNA to DNA ratio of the two
in situ kidneys in this system are exactly those of the remaining
right kidney in a single rat after left nephrectomy. Although
these results were anticipated by earlier studies of isologous
mice in cutaneous parabiosis [10], that model was perforce
affected by slow mixing of the circulations and the long duration
of the experiments.
After the appropriate increase in renal mass and the expected
plateau of RNAIDNA are reached following 48 hr of crosscircu-
lation, separation of the rats is followed by partial regression of
renal mass within 6 hr and a return of both mass and RNA/DNA
to baseline by 12 hr [91. Moreover, transplantation of a normal
isologous kidney to a rat with renal hypertrophy as a result of a
previous unilateral nephrectomy also causes the hypertrophied
kidney to regress to normal [11, 12].
The response to crosscirculation is repeatable, proportional
to the amount of lost renal mass, and capable of changing from
hypertrophy to hyperplasia if enough is lost. That is, after
disconnection of crosscirculation and regression to normal of
hypertrophied kidneys in the crosscirculation model, re-estab-
lishment of vascular parabiosis with another anephric rat makes
in situ kidneys grow as they did previously [13]. Removing
three kidneys between the parabiotic pair enhances compensa-
tory growth of the solitary kidney. Removal of five of six
kidneys among three rats in vascular parabiosis stimulates
compensatory growth characterized by intense hyperplasia,
rather than by hypertrophy [13].
Caveats
I think those clinical and experimental observations are valid
because they deal with the simplest and most evident aspects of
renal hypertrophy [14]; furthermore, they show a stimulatory
response. Results assayed by the incorporation of radioactive
precursors and those adducing a circulating depressant factor
are confounded by so many variables that the definitive experi-
ment has probably not been done. The general level of skepti-
cism is such that almost no system devised in one laboratory
has been adopted by another.
In supporting these assertions and explaining my reserva-
tions, I shall have to overlap to some extent the subject of
Yamamoto's review elsewhere in this issue. I am afraid I shall
make no new friends—and lose some old ones.
Nutrition and growth. The nutritional status of animals in
experimental and control groups must be identical. Poor diet
and operative trauma depress renal hypertrophy [2, 15—17].
Spurious results caused by deleterious systemic effects of
injection of tissue extracts, by overlooking decreased weight
associated with hypophysectomy, and by failing to provide Na
in the drinking water of adrenalectomized or hypophysecto-
mized rats have all been documented [1, 18—20]. To the
contrary, a high protein diet or one relatively richer in casein
than in gelatin enhances renal growth, although the mechanism
may not be the same one involved in compensatory renal
hypertrophy [2 1—23]. Because both exogenous protein and urea
stimulate renal growth, although probably not by the same
mechanisms as in renoprival hypertrophy, inferences about
responses following parenteral injections of urine are difficult.
Therefore, when pair-feeding schedules are not used [24],
when effects of different kinetics of weight gain are not ana-
lyzed, or when allometric comparisons are not made [25],
results of manipulating putative regulators of compensatory
renal hypertrophy are debatable. This caveat applies particular-
ly to the reports of regulators said to work by depressing renal
hypertrophy as opposed to those supposed to be stimulants,
inasmuch as any non-nutritive substance that stimulates true
renoprival compensatory hypertrophy is interesting, even if the
experimental control animals are not nutritionally equivalent.
Genetic and hormonal controls. Inferences derived from
responses days to weeks after injection of extracts or subcellu-
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lar fractions from one member of an outbred species into
another are likely to be influenced at best by minor degrees of
immunologic rejection and at worst by graft-versus-host dis-
ease. Appropriate controls for these phenomena as well as for
the nutritional state of experimental animals are required before
results can be accepted.
Androgens are powerful stimulants of renal hypertrophy, but
not through the same mechanism as loss of renal tissue [26—29].
Using serum from male animals in which to incubate slices of
kidney from females is unacceptable. (Also see What the
stimulus is not section of this paper.) Renal growth after
parenteral injections of pharmacologic doses of hormones is not
renoprival growth.
Organ controls. For reasons given above, sham nephrecto-
my, sham removal of endocrine glands, and injection of an
inactivated preparation of a substance being tested as a regula-
tor are mandatory controls for particular systems. Use of
normal animals and injections of solvents alone are not appro-
priate. Use of the kidney first removed as the control for the
one later removed is reasonable only if allometric compensation
is introduced insofar as changes in mass are concerned and if
the possibility of maturation of certain metabolic systems from
the time of the first kidney was removed to the time of sacrifice
of the second kidney is considered.
Using liver as the control for kidney in the same animal is
uncertain. Between the two organs the number and kind of
receptors, the transport mechanisms, and the metabolic path-
ways may differ considerably with respect to the substance
being examined. In addition, unilateral nephrectomy may
change hepatic metabolism: for example, inhibiting the radioac-
tive thymidine labeling index of liver [30].
Radioactive precursors. The first consideration in precursor-
product relations is to establish that the product thought to be
measured is the one actually measured. Assays of radioactivity
in an acid-precipitable product after injection of a radioactive
precursor are insufficient. Many precursors can be used in
pathways of synthesis for other macromolecules—uridine be-
coming incorporated into protein, for example. Specific identifi-
cation of the identity and purity of the substance used as the
assay of growth is thus mandatory [311.
But without measurement of the radioactivity in precursor
pools, results of assays of radioactive acid-precipitable prod-
ucts are arguable [32—34]. The rate of incorporation of precursor
into the final product is dependent upon the concentration of
the precursor, its site and rate of transport, its metabolic
conversions, and ultimately upon the specific radioactivity of
the metabolite that is the immediate precursor of the final
product in the metabolic compartment specific for the product.
In renal hypertrophy, studies of specific activity and absolute
rates of synthesis have been done with respect to nucleic acid
pools and the conversion of radioactive UTP and CTP to RNA.
The answers differ: one group saying that RNA synthesis is
increased early during renal hypertrophy in the rat [35], the
other saying not in the mouse [36, 37]. Measurements of
radioactivity in mononucleotides like UMP are not relevant
[38]. Compensation for the specific activity of TTP poois in
studies following the injection of 3HTdR do not seem to have
been done but should be if DNA synthesis is being analyzed as a
hallmark of renal hypertrophy, especially as thymidine kinase
activity is increased about 2.5-fold [39].
Leucine incorporation into renal protein follows pulse-chase
kinetics, thereby making it excellent in that respect [40].
Nonetheless, poois still have to be measured because the pool
of free amino acids increases during renal hypertrophy [411.
Finally, radioautographs should be examined before conclu-
sions are drawn. Orotic acid as a precursor. for example,
localizes chiefly in the proximal tubule cells (the major site of
compensatory renal hypertrophy), but uridine is more generally
distributed [42].
RNA, DNA, andprotein as assays. Increases even of "cold"
DNA, RNA, and protein in assays for humoral regulators of
compensatory renal growth are not unequivocal. An increase in
the mass of any one of these products is not synonymous with
an increased rate of synthesis of that product.
In the first place, a decreased rate of degradation of ribosom-
al protein and of RNA during renal hypertrophy might have to
be invoked. Decreased degradation may be sufficient to account
for much of the increment in RNA and ribosomal protein during
early renal hypertrophy in the mouse [37, 40].
Second, the rodent kidney is unusual in that it normally
transports large amounts of protein. In the rat, reabsorption of
infused protein is normally greater than 91% complete, mostly
in the proximal tubules and probably varies with the charge of
the protein [43, 44], Because an increased rate of protein
synthesis sufficient to produce a 10% increase in protein
content 4 hr after rat kidney slices are incubated in plasma from
unilaterally nephrectomized rats [45] exceeds conventional
thermodynamic expectations of what a stimulator is capable of
evoking, a change in transport may have to be advanced as part
of the explanation for that phenomenon.
Third, increased amounts of "cold" macromolecules and
trace amounts of macromolecules recognized by their incorpo-
ration of radioactivity or their ability to stimulate protein
synthesis in vitro could be found if "experimental" serum,
urine, or extracts from a nephrectomized animal contains
nutrients, elongation factors, and energy sources not available
in controls. This problem needs to be examined with respect to
the novel system showing stimulation of translation products
directed by renal mRNA after perfusion of a kidney with an
extract of hypertrophied cardiac muscle [46, 47].
Fourth, since injection of human serum albumin may cause a
non-immunologically mediated, permanent protein-losing
nephropathy in the rat [48], administration of other proteins
such as those contained in many extracts of putative regulatory
substances for renal growth may also precipitate abnormalities
in renal metabolism. Compensatory growth in these circum-
stances may be only to compensate for damage.
Fifth, the experimental circumstances may themselves
change metabolism. When placed in vitro rat kidney slices and
other cells synthesize a novel "heat-shock" protein, thereby
changing both their rate of protein synthesis and the spectrum
of proteins synthesized [49, 50].
Mitotic counts as assay. The mitotic index is not a good
standard. Compensatory renal hype rt rophy is characterized by
an increase in size of cells, not their number, granted that
extreme loss of renal mass provokes hyperplasia rather than
hypertrophy as the chief response. Whatever contribution
hyperplasia normally makes to compensatory growth is a
sufficient condition, but not a necessary one, inasmuch as
hyperplasia can he eliminated by treatment with hydroxyurea
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or azathioprine without altering the course of compensatory
renal growth [51, 52].
Moreover, cell division does not necessarily mean growth.
Mitosis can equally be an index of cell damage. Ostensibly
inconsequential handling of a normal mouse kidney causes
intense mitosis and uptake of radioactive thymidine [53]. Simi-
lar responses in vivo and in vitro may be expected after
application of serum containing toxic metabolites or an imbal-
ance of them. Indeed, minor mechanical damage to one mouse
kidney incites a mitotic response in the other [541.
Pharmacokinetics. The magnitude of compensatory renal
hypertrophy is proportional to the loss. The response to stimuli
should also be graduated. An all-or-none response or a nongrad-
ed response produced by nominal regulators of renal hypertro-
phy, applied at an arbitrary time and for an arbitrary duration, is
inconsistent with the properties and responses of most humoral
regulators [55—571. Even when an all-or-none response is elicit-
ed, experiments must show whether the action is pharmacolog-
ic or physiologic and whether it is a consequence of adventitial
changes in binding to receptors or of the actual response being
sought. Considering (1) the assertions in this paragraph and the
two preceding it, (2) the large volume of crosscirculating blood
from an anephric rat necessary to provoke compensatory
hypertrophy in a normal rat connected to it in the crosscircula-
tion model and, (3) the regression of hypertrophy within 6 hr of
disconnection, an increase in the radioactive thymidine labeling
index of a rat kidney after twice-daily intraperitoneal injections
of 0.5 ml serum for 4 days from rats killed 48 hr after unilateral
nephrectomy [581 may not necessarily represent specific evi-
dence of a physiologic stimulus [59, 601.
Statistics. Parametric statistics apply to normally distributed
data. Most data from experiments on regulators of renal hyper-
trophy are not normal; many are bimodal and some are trimo-
dal. Although Student's t test is robust enough to handle some
nonparametric data, it is not ideal for most statistics concerning
the issue here. Simple nonparametric tests like the Wilcoxon
rank sum (or slightly more complex ones) would be preferable.
Analysis of variance may be required.
What the stimulus is not
Studies excluding substances as regulators of renal hypertro-
phy are often easier to interpret; some have even been con-
firmed. Because hypertrophy occurs normally in the Little
dwarf mouse, it is not determined by the presence of somatotro-
pin [611. Its occurrence in the Snell dwarf mouse [62] and in
mice with hypothalamic destruction tends to remove other
pituitary hormones from consideration [631. Its occurrence in
the mouse with testicular feminization (lacking the testosterone
receptor) [641 exonerates androgens. Absence of compensatory
hypertrophy in blind and anosmic rats [651 requires controls
necessary for the J3-error in negative observations. Transfers of
serum from a recently hypophysectomized rat to a culture
system as an assay of a regulator of compensatory renal
hypertrophy [661 may be confounded by the catabolic state of
the animals. Impaired hypertrophy in hypothyroidism may be a
general defect of energy metabolism [671. Renal hypertrophy is
not impaired in streptozotocin-induced diabetes [681; it is
impaired in hypophysectomized rats given nonsuppressible
insulin-like activity (NSILA, a species of somatomedin) [691. It
is independent of most of the abdominal viscera [701.
Although immune competence has been invoked as a regula-
tory action, compensatory renal hypertrophy is unchanged in
mice subjected to neonatal thymectomy [71]. Experiments with
nude mice, which would be a better system, have not been
reported.
The factor does not seem to be one that is both excreted into
the renal vein and inactivated by the liver [72]. That is, the
kinetics of hypertrophy are unchanged in rats undergoing total
diversion of the effluent from one renal vein into the portal
circulation.
The presence of abnormal amounts of protein, such as
ribonuclease [73] and a-globulin [74], in a rat kidney undergoing
compensatory hypertrophy is most likely a consequence of
increased tubular reabsorption of protein by that kidney. The
role of arginylesteropeptidase [75] awaits confirmation of the
antecedent experiments [24, 661.
What the stimulus is
For many years the visible hyperemia of the rodent kidney
soon after contralateral nephrectomy and an immediate in-
crease of 16 to 50% in flow through the dog's renal artery
seemed like excellent leads in a search for a vasoactive sub-
stance as the stimulator of renal hypertrophy. Although one
recent paper has questioned the validity of the canine experi-
ments [76], another has confirmed observations in rats [77]. I
accept data showing an increased blood flow since they support
what one sees. Moreover, hyperemia occurs so rapidly it would
be disappointing if if were an epiphenomenon.
Since I have speculated that the stimulus (stimuli) might be an
active moiety released from an inactive precursor [2], it would
be pleasing if it were a simple peptide hormone or a vasoactive
substance suddenly split from its precursor or released from
binding with protein. A stimulating substance specific for
hepatic tissue has a molecular weight of 10,000 and contains no
insulin, glucagon, epidermal growth factor or somatomedin
when tested by radioimmunoassay [781. Stimulators in the urine
and the "work hypothesis" are considered by Harris and Best
elsewhere in this symposium issue. Perhaps those substances or
other growth factors act directly and simply by stimulating renal
cell proliferation as a consequence of increasing transcellular
gradients of Na [79] or K [80], which in turn somehow
increase phosphorylation of regulatory proteins [81].
Summary. Compensatory renal hypertrophy in transplanted
kidneys shows that the major regulators are humoral. Crosscir-
culation experiments are confirmatory indicating further that
the regulators are short-lived and must be consistently present
during the early phases of hypertrophy. Controls are difficult to
achieve in other systems; variables relate to nutrition, means of
assay, pharmacokinetics, and abnormalities produced by the
experimental model itself. A simple hypothesis to account for
the events precipitating renal hypertrophy might integrate the
onsets of renal hyperemia soon after contralateral nephrectomy
with the activation of pre-existing stimulators specific for the
kidney.
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